Skip to content
10-Q

Quarterly Report

CORTRONIX BIOMEDICAL ADVANCEMENT TECHNOLOGIES INC.

0001594062-14-000155

← back to feed
Filed
May 7, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · May 6, 2014 349.5M sh
Shares Diluted Q2 2014 · Feb 28, 2014 349.5M sh
Shares Diluted Q2 2014 · Feb 28, 2014 321.88M sh
Shares Diluted Q2 2014 · Feb 28, 2013 287M sh
Shares Diluted Q2 2014 · Feb 28, 2013 280.19M sh
Operating Cash Flow Q2 2014 · Feb 28, 2014 −$16.12K
Operating Cash Flow Q2 2014 · Feb 28, 2014 −$307.14K
Operating Cash Flow Q2 2014 · Feb 28, 2013 −$218.05K
Cash And Equivalents Q2 2014 · Feb 28, 2014 $16
Cash And Equivalents Q2 2014 · Aug 31, 2013 $640
Cash And Equivalents Q2 2014 · Feb 28, 2013 $26.16K
Cash And Equivalents Q2 2014 · Aug 31, 2012 $31.69K
Stockholders Equity Q2 2014 · Feb 28, 2014 −$1.18M
Stockholders Equity Q2 2014 · Aug 31, 2013 −$1.05M
Current Liabilities Q2 2014 · Feb 28, 2014 $1.26M
Current Liabilities Q2 2014 · Aug 31, 2013 $1.14M
Current Assets Q2 2014 · Feb 28, 2014 $60.39K
Current Assets Q2 2014 · Aug 31, 2013 $61.02K
Total Assets Q2 2014 · Feb 28, 2014 $78.03K
Total Assets Q2 2014 · Aug 31, 2013 $85.37K
Sga Expense Q2 2014 · Feb 28, 2014 $3.17K
Sga Expense Q2 2014 · Feb 28, 2014 $15.51K
Sga Expense Q2 2014 · Feb 28, 2014 $134.24K
Sga Expense Q2 2014 · Feb 28, 2013 $27.06K
Sga Expense Q2 2014 · Feb 28, 2013 $58.45K
Net Income Q2 2014 · Feb 28, 2014 −$87.76K
Net Income Q2 2014 · Feb 28, 2014 −$5.13M
Net Income Q2 2014 · Feb 28, 2014 −$5.58M
Net Income Q2 2014 · Feb 28, 2013 −$116.35K
Net Income Q2 2014 · Feb 28, 2013 −$218.57K
Operating Income Q2 2014 · Feb 28, 2014 −$67.09K
Operating Income Q2 2014 · Feb 28, 2014 −$4.32M
Operating Income Q2 2014 · Feb 28, 2014 −$4.7M
Operating Income Q2 2014 · Feb 28, 2013 −$97.35K
Operating Income Q2 2014 · Feb 28, 2013 −$184.95K